Skip to main content

Advertisement

Log in

Interleukin-6 promotes systemic lupus erythematosus progression with Treg suppression approach in a murine systemic lupus erythematosus model

  • Original Article
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Abstract

Our aim is to reveal the role of interleukin 6 (IL-6) in the pathogenesis of systemic lupus erythematosus (SLE) in a murine model of SLE. Normal female C57BL/6 mice were immunized with syngeneic-activated lymphocyte-derived DNA (ALD-DNA) to induce SLE. Non-immunized mice were used as control. SLE-associated markers, including anti-double-stranded DNA (anti-dsDNA) Abs, urine protein, and kidney histopathology, were assayed to ensure the induction of the disease. Compared with control mice, ALD-DNA immunized mice exhibited high levels of anti-dsDNA Abs, IL-6 expression in vivo and in vitro. We also found that IL-6 knockout (IL-6KO) mice were resistant to ALD-DNA-induced SLE. The activation of CD4+ T cells in immunized IL-6KO mice was lower than in immunized wild-type (Wt) mice. Intracellular cytokine staining showed that Foxp3 expression in immunized IL-6KO mice was higher than in immunized Wt mice, which might be associated with the disease severity. We further discovered that ALD-DNA-stimulated dendritic cells supernatants could result in higher IL-6 and TNF-α expression and could suppress Foxp3 expression. In addition, blocking IL-6 could up-regulate Foxp3 expression. Therefore, our findings show that IL-6 promotes the progression of SLE via suppressing Treg differentiation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. Tan EM (1989) Antinuclear antibodies: diagnostic markers for autoimmune diseases and probes for cell biology. Adv Immunol 44:93–151

    Article  PubMed  CAS  Google Scholar 

  2. Vlahakos DV, Foster MH, Adams S, Katz M, Ucci AA, Barrett KJ, Datta SK, Madaio MP (1992) Anti-DNA antibodies form immune deposits at distinct glomerular and vascular sites. Kidney Int 41(6):1690–1700

    Article  PubMed  CAS  Google Scholar 

  3. Tebbe B, Orfanos CE (1997) Epidemiology and socioeconomic impact of skin disease in lupus erythematosus. Lupus 6(2):96–104

    Article  PubMed  CAS  Google Scholar 

  4. Qiao B, Wu J, Chu YW, Wang Y, Wang DP, Wu HS, Xiong SD (2005) Induction of systemic lupus erythematosus-like syndrome in syngeneic mice by immunization with activated lymphocyte-derived DNA. Rheumatology (Oxford) 44(9):1108–1114

    Article  CAS  Google Scholar 

  5. Wen ZK, Xu W, Xu L, Cao QH, Wang Y, Chu YW, Xiong SD (2007) DNA hypomethylation is crucial for apoptotic DNA to induce systemic lupus erythematosus-like autoimmune disease in SLE-non-susceptible mice. Rheumatology (Oxford) 46(12):1796–1803

    Article  CAS  Google Scholar 

  6. Wen Z, Xu L, Xu W, Xiong S (2012) Production of anti-double-stranded DNA antibodies in activated lymphocyte derived DNA induced lupus model was dependent on CD4+ T cells. Lupus 21(5):508–516

    Article  PubMed  CAS  Google Scholar 

  7. Hurst SM, Wilkinson TS, McLoughlin RM, Jones S, Horiuchi S, Yamamoto N, Rose-John S, Fuller GM, Topley N, Jones SA (2001) Il-6 and its soluble receptor orchestrate a temporal switch in the pattern of leukocyte recruitment seen during acute inflammation. Immunity 14(6):705–714

    Article  PubMed  CAS  Google Scholar 

  8. Tanaka T, Kishimoto T (2012) Targeting interleukin-6: all the way to treat autoimmune and inflammatory diseases. Int J Biol Sci 8(9):1227–1236

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  9. al-Janadi M, al-Balla S, al-Dalaan A, Raziuddin S (1993) Cytokine profile in systemic lupus erythematosus, rheumatoid arthritis, and other rheumatic diseases. J Clin Immunol 13(1):58–67

    Article  PubMed  CAS  Google Scholar 

  10. Linker-Israeli M, Deans RJ, Wallace DJ, Prehn J, Ozeri-Chen T, Klinenberg JR (1991) Elevated levels of endogenous IL-6 in systemic lupus erythematosus. A putative role in pathogenesis. J Immunol 147(1):117–123

    PubMed  CAS  Google Scholar 

  11. Aringer M, Smolen JS (2005) Cytokine expression in lupus kidneys. Lupus 14(1):13–18

    Article  PubMed  CAS  Google Scholar 

  12. Smolen JS, Steiner G, Aringer M (2005) Anti-cytokine therapy in systemic lupus erythematosus. Lupus 14(3):189–191

    Article  PubMed  CAS  Google Scholar 

  13. Qian Y, Conway KL, Lu X, Seitz HM, Matsushima GK, Clarke SH (2006) Autoreactive MZ and B-1 B-cell activation by Faslpr is coincident with an increased frequency of apoptotic lymphocytes and a defect in macrophage clearance. Blood 108(3):974–982

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  14. Ito T, Schaller M, Hogaboam CM, Standiford TJ, Sandor M, Lukacs NW, Chensue SW, Kunkel SL (2009) TLR9 regulates the mycobacteria-elicited pulmonary granulomatous immune response in mice through DC-derived Notch ligand delta-like 4. J Clin Invest 119(1):33–46

    PubMed  CAS  PubMed Central  Google Scholar 

  15. Zhang W, Xu W, Xiong S (2010) Blockade of Notch1 signaling alleviates murine lupus via blunting macrophage activation and M2b polarization. J Immunol 184(11):6465–6478

    Article  PubMed  CAS  Google Scholar 

  16. Zhang W, Xu W, Xiong S (2011) Macrophage differentiation and polarization via phosphatidylinositol 3-kinase/Akt-ERK signaling pathway conferred by serum amyloid P component. J Immunol 187(4):1764–1777

    Article  PubMed  CAS  Google Scholar 

  17. Zhang W, Wu J, Qiao B, Xu W, Xiong S (2011) Amelioration of lupus nephritis by serum amyloid P component gene therapy with distinct mechanisms varied from different stage of the disease. PLoS ONE 6(7):e22659

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  18. Mevorach D, Zhou JL, Song X, Elkon KB (1998) Systemic exposure to irradiated apoptotic cells induces autoantibody production. J Exp Med 188(2):387–392

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  19. Yin Z, Zhang DH, Welte T, Bahtiyar G, Jung S, Liu L, Fu XY, Ray A, Craft J (2000) Dominance of IL-12 over IL-4 in gamma delta T cell differentiation leads to default production of IFN-gamma: failure to down-regulate IL-12 receptor beta 2-chain expression. J Immunol 164(6):3056–3064

    Article  PubMed  CAS  Google Scholar 

  20. Wen Z, Xu L, Xu W, Yin Z, Gao X, Xiong S (2013) Interleukin-17 expression positively correlates with disease severity of lupus nephritis by increasing anti-double-stranded DNA antibody production in a lupus model induced by activated lymphocyte derived DNA. PLoS ONE 8(3):e58161

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  21. Pisitkun P, Ha HL, Wang H, Claudio E, Tivy CC, Zhou H, Mayadas TN, Illei GG, Siebenlist U (2012) Interleukin-17 cytokines are critical in development of fatal lupus glomerulonephritis. Immunity 37(6):1104–1115

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  22. Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M (1995) Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 155(3):1151–1164

    PubMed  CAS  Google Scholar 

  23. Kotzin BL (1996) Systemic lupus erythematosus. Cell 85(3):303–306

    Article  PubMed  CAS  Google Scholar 

  24. Nath SK, Kilpatrick J, Harley JB (2004) Genetics of human systemic lupus erythematosus: the emerging picture. Curr Opin Immunol 16(6):794–800

    Article  PubMed  CAS  Google Scholar 

  25. Grondal G, Gunnarsson I, Ronnelid J, Rogberg S, Klareskog L, Lundberg I (2000) Cytokine production, serum levels and disease activity in systemic lupus erythematosus. Clin Exp Rheumatol 18(5):565–570

    PubMed  CAS  Google Scholar 

  26. Rose-John S, Waetzig GH, Scheller J, Grotzinger J, Seegert D (2007) The IL-6/sIL-6R complex as a novel target for therapeutic approaches. Expert Opin Ther Targets 11(5):613–624

    Article  PubMed  CAS  Google Scholar 

  27. Kaplanski G, Marin V, Montero-Julian F, Mantovani A, Farnarier C (2003) IL-6: a regulator of the transition from neutrophil to monocyte recruitment during inflammation. Trends Immunol 24(1):25–29

    Article  PubMed  CAS  Google Scholar 

  28. Alvarado-Sanchez B, Hernandez-Castro B, Portales-Perez D, Baranda L, Layseca-Espinosa E, Abud-Mendoza C, Cubillas-Tejeda AC, Gonzalez-Amaro R (2006) Regulatory T cells in patients with systemic lupus erythematosus. J Autoimmun 27(2):110–118

    Article  PubMed  CAS  Google Scholar 

  29. Okabe Y, Kawane K, Akira S, Taniguchi T, Nagata S (2005) Toll-like receptor-independent gene induction program activated by mammalian DNA escaped from apoptotic DNA degradation. J Exp Med 202(10):1333–1339

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  30. Garrett-Sinha LA, John S, Gaffen SL (2008) IL-17 and the Th17 lineage in systemic lupus erythematosus. Curr Opin Rheumatol 20(5):519–525

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

This work was supported by grants to Dr. Z. Yin from the National Science Foundation of China (31230025), the International S&T Cooperation Program of China (2010DFB3400), and the National Basic Research Grant of China (2010CB529100). It was also supported by grants from the National Science Foundation of China (31170858, 31370883 to Dr. L. Zhao, and 31000400 to Dr. Z. Wu). We thank Charron Cote for editing the manuscript.

Disclosure

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Zhinan Yin.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Mao, X., Wu, Y., Diao, H. et al. Interleukin-6 promotes systemic lupus erythematosus progression with Treg suppression approach in a murine systemic lupus erythematosus model. Clin Rheumatol 33, 1585–1593 (2014). https://doi.org/10.1007/s10067-014-2717-9

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-014-2717-9

Keywords

Navigation